YUM
45
-4
KO
57
-2
ACN
65
2
KSS
42
4
IRM
50
-2
BK
82
2
LB
64
11
VRSN
64
-2
PHM
50
-2
STT
79
3
SYY
44
-4
NEM
53
-2
CCI
15
-2
D
38
-5
WU
28
-10
UNP
46
-4
MCD
39
-3
PBI
58
3
STZ
34
-3
PFE
26
-3
YUM
45
-4
KO
57
-2
ACN
65
2
KSS
42
4
IRM
50
-2
BK
82
2
LB
64
11
VRSN
64
-2
PHM
50
-2
STT
79
3
SYY
44
-4
NEM
53
-2
CCI
15
-2
D
38
-5
WU
28
-10
UNP
46
-4
MCD
39
-3
PBI
58
3
STZ
34
-3
PFE
26
-3
Financhill
Back

Repligen Stock Predictions

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Sell
40

RGEN
Repligen

Last Price:
$127.96
Seasonality Move:
4.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Repligen Stock Forecast

  • Over the next 52 weeks, Repligen has on average historically risen by 17.9% based on the past 38 years of stock performance.
  • Repligen has risen higher in 21 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.26%
  • Is Repligen Stock Undervalued?
    The current Repligen [RGEN] share price is $131.55. The Score for RGEN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Repligen Stock Go Up Next Year?

  • Over the next 52 weeks, Repligen has on average historically risen by 17.9% based on the past 38 years of stock performance.

Repligen Stock Rating

Sell
40
Repligen (RGEN) is a Sell

Is Repligen overpriced?

  • Repligen has risen higher in 21 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.26%

Repligen Stock Price History

Is RGEN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com

52-Week Data

52-Week High:
182.52
52-Week Low:
102.97

Prediction Charts

Market Cap:
7.4B
Price in USD:
131.55
Volume:
546.9K
Beta:
0.99

Technical Analysis

SMA50:
136.55
SMA100:
146.32
SMA200:
145.96
52-Wk Change:
-19.46%

Stock Predictions

  • Is Repligen stock public?
    Yes, Repligen is a publicly traded company.
  • What is the Repligen stock quote today?
    The Repligen stock price is 131.55 USD today.
  • How to buy Repligen stock online?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-24 141.81 145.23 145.91 140.70
Apr-25 143.75 144.75 145.96 140.89
Apr-28 145.60 143.63 148.38 140.14
Apr-29 135.15 139.43 145.47 132.46
Apr-30 139.54 137.99 139.54 134.04
May-1 139.75 137.20 140.71 135.46
May-2 140.36 141.51 142.66 138.32
May-5 140.28 140.92 143.56 139.68
May-6 140.21 130.40 141.99 130.15
May-7 131.52 126.88 133.18 125.31
May-8 127.82 127.85 131.00 126.27
May-9 128.36 123.24 130.87 123.10
May-12 127.86 133.72 134.06 125.40
May-13 133.53 131.55 135.47 131.37

Repligen Earnings

Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.

Repligen Forecast Revenue Growth

Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.14 per share, an increase this year of $0.14 per share, and an increase next year of $0.49 per share.

* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.